Ekaterina Malievskaia, co-founder of Compass Pathways recently published a statement about the company’s psilocybin research program, including a section about “MANUFACTURING AND PATENTING” psilocybin. See MAPS website. The statement appears …
Yield Growth subsidiary Flourish Mushroom Labs appears to have discovered a fundamentally new use for the active compounds in magic mushrooms, i.e. psilocin and its prodrug psilocybin. On December 10, …
Silo Wellness just announced the world’s first metered-dose magic mushroom nasal spray. The nasal spray formulation was designed to provide users with rapidly absorbed and predictable doses of “full spectrum” …
Based on newfound benefits of magic mushrooms and the changing cultural (and legal) climate, some early movers have started working on psilocybin containing consumer products, like foods and beverages. On …
Formulations made from magic mushrooms offer some advantages over mushroom fruiting bodies or natural preparations. We previously discussed the analogy between cannabis and magic mushrooms. Both cannabis and magic mushrooms …
On May 17, 2019, Wuhan General Group (“Wuhan”) announced signing a Letter of Intent (“LOI”) with Biodelta Nutraceuticals, Ltd. This announcement follows Wuhan’s April 5, 2019 announcement that its wholly-owned …
In late April of 2019, both the United States Patent and Trademark Office (“USPTO”) and the World Intellectual Property Office (“WIPO”) published Compass Pathways’s Patent Applications directed to psilocybin technology. …
The increasing interest in psychedelic investment opportunities, including some recent developments in China, has led some analysts to begin studying the psychedelic patent landscape. Given the relatively small amount of …
** See also recent article on “Investing in Psychedelics – a 2020 Perspective” ** [Updated December 2019] Are magic mushrooms (or psilocybin) going to be the next big investment opportunity …
On April 05, 2019, Wuhan General Group, Inc. announced that its subsidiary MJ MedTech, Inc. (MJ MedTech) has created a new division dedicated to exploring opportunities in the psychedelic medicine …
